Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Orni-Wasserlauf
R
R
Infectious Disease Unit, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel. zihum@tasmc.health.gov.il.
Izkhakov
E
E
Siegman-Igra
Y
Y
Bash
E
E
Polacheck
I
I
Giladi
M
M
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D003453:Cryptococcosis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000187:drug effects* / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000627:therapeutic use*; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008581:Meningitis / Q000150:complications / Q000188:drug therapy
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine